Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction
AIM: To investigate whether dimethyl sulfoxide(DMSO) inhibits gut inflammation and barrier dysfunction following zymosan-induced systemic inflammatoryresponse syndrome and multiple organ dysfunction syndrome.METHODS: Sprague-Dawley rats were randomly divided into four groups: sham with administratio...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2015-10, Vol.21 (38), p.10853-10865 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 10865 |
---|---|
container_issue | 38 |
container_start_page | 10853 |
container_title | World journal of gastroenterology : WJG |
container_volume | 21 |
creator | Li, Yu-Meng Wang, Hai-Bin Zheng, Jin-Guang Bai, Xiao-Dong Zhao, Zeng-Kai Li, Jing-Yuan Hu, Sen |
description | AIM: To investigate whether dimethyl sulfoxide(DMSO) inhibits gut inflammation and barrier dysfunction following zymosan-induced systemic inflammatoryresponse syndrome and multiple organ dysfunction syndrome.METHODS: Sprague-Dawley rats were randomly divided into four groups: sham with administration of normal saline(SS group); sham with administration of DMSO(SD group); zymosan with administration of normal saline(ZS group); and zymosan with administration of DMSO(ZD group). Each group contained three subgroups according to 4 h,8 h,and 24 h after surgery. At 4 h,8 h,and 24 h after intraperitoneal injection of zymosan(750 mg/kg),the levels of intestinal inflammatory cytokines [tumor necrosis factor-alpha(TNF-α) and interleukin(IL)-10] and oxides(myeloperoxidase,malonaldehyde,and superoxide dismutase) were examined. The levels of diamine oxidase(DAO) in plasma and intestinal mucosal blood flow(IMBF) were determined. Intestinal injury was also evaluated using an intestinal histological score and apoptosis of intestinal epithelial cells was determined by deoxynucleotidyl transferase d UTP nick end labeling(TUNEL) assay. The intestinal epithelial tight junction protein,ZO-1,was observed by immunofluorescence.RESULTS: DMSO decreased TNF-α and increased IL-10 levels in the intestine compared with the ZS group at the corresponding time points. The activity of intestinal myeloperoxidase in the ZS group was higher than that in the ZD group 24 h after zymosan administration(P < 0.05). DMSO decreased the content of malondialdehyde(MDA) and increased the activity of superoxide dehydrogenase(SOD) 24 h after zymosan administration. The IMBF was lowest at 24 h and was 49.34% and 58.26% in the ZS group and ZD group,respectively(P < 0.05). DMSO alleviated injury in intestinal villi,and the gut injury score was significantly lower than the ZS group(3.6 ± 0.2 vs 4.2 ± 0.3,P < 0.05). DMSO decreased the level of DAO in plasma compared with the ZS group(65.1 ± 4.7 U/L vs 81.1 ± 5.0 U/L,P < 0.05). DMSO significantly preserved ZO-1 protein expression and localization 24 h after zymosan administration. The TUNEL analysis indicated that the number of apoptotic intestinal cells in the ZS group was much higher than the ZD group(P < 0.05).CONCLUSION: DMSO inhibited intestinal cytokines and protected against zymosan-induced gut barrier dysfunction. |
doi_str_mv | 10.3748/wjg.v21.i38.10853 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4600586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849535156484954</cqvip_id><sourcerecordid>1724261548</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-6aaa329c23cb795ae57e0cfbcecabccb02aa15ee0a9fabd65f93f5c193edfb313</originalsourceid><addsrcrecordid>eNpVkU9v1DAQxS0EokvhA3BBOXLJ4r-JfUFChQJSJS7tiYM1duxdV4nd2klh--nxtsuqncuM_N482_oh9J7gNeu5_PTnerO-o2QdmFwTLAV7gVaUEtVSyfFLtCIY961itD9Bb0q5xpgyJuhrdEI73suu71bo99cwuXm7G5uyjD79DYNrQtwGE-bS3O-mVCC2IQ6LdUMVZlfmEGGsox9hmmAOKTYQh8ZAzsHlZtgVv0S7P3-LXnkYi3t36Kfo6vzb5dmP9uLX959nXy5ayzmb2w4AGFWWMmt6JcCJ3mHrjXUWjLUGUwAinMOgPJihE14xLyxRzA3eMMJO0efH3JvFTG6wLs4ZRn2TwwR5pxME_VyJYas36U7zDmMhuxrw8RCQ0-1Sv6inUKwbR4guLUWTnnLaEcFltZJHq82plOz88RqC9R6KrlB0haIrFP0Ape58ePq-48Z_CtXADqHbFDe3IW6OHoXlvpTAXHIlmCCie5g4-weAQ545</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1724261548</pqid></control><display><type>article</type><title>Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Li, Yu-Meng ; Wang, Hai-Bin ; Zheng, Jin-Guang ; Bai, Xiao-Dong ; Zhao, Zeng-Kai ; Li, Jing-Yuan ; Hu, Sen</creator><creatorcontrib>Li, Yu-Meng ; Wang, Hai-Bin ; Zheng, Jin-Guang ; Bai, Xiao-Dong ; Zhao, Zeng-Kai ; Li, Jing-Yuan ; Hu, Sen</creatorcontrib><description>AIM: To investigate whether dimethyl sulfoxide(DMSO) inhibits gut inflammation and barrier dysfunction following zymosan-induced systemic inflammatoryresponse syndrome and multiple organ dysfunction syndrome.METHODS: Sprague-Dawley rats were randomly divided into four groups: sham with administration of normal saline(SS group); sham with administration of DMSO(SD group); zymosan with administration of normal saline(ZS group); and zymosan with administration of DMSO(ZD group). Each group contained three subgroups according to 4 h,8 h,and 24 h after surgery. At 4 h,8 h,and 24 h after intraperitoneal injection of zymosan(750 mg/kg),the levels of intestinal inflammatory cytokines [tumor necrosis factor-alpha(TNF-α) and interleukin(IL)-10] and oxides(myeloperoxidase,malonaldehyde,and superoxide dismutase) were examined. The levels of diamine oxidase(DAO) in plasma and intestinal mucosal blood flow(IMBF) were determined. Intestinal injury was also evaluated using an intestinal histological score and apoptosis of intestinal epithelial cells was determined by deoxynucleotidyl transferase d UTP nick end labeling(TUNEL) assay. The intestinal epithelial tight junction protein,ZO-1,was observed by immunofluorescence.RESULTS: DMSO decreased TNF-α and increased IL-10 levels in the intestine compared with the ZS group at the corresponding time points. The activity of intestinal myeloperoxidase in the ZS group was higher than that in the ZD group 24 h after zymosan administration(P &lt; 0.05). DMSO decreased the content of malondialdehyde(MDA) and increased the activity of superoxide dehydrogenase(SOD) 24 h after zymosan administration. The IMBF was lowest at 24 h and was 49.34% and 58.26% in the ZS group and ZD group,respectively(P &lt; 0.05). DMSO alleviated injury in intestinal villi,and the gut injury score was significantly lower than the ZS group(3.6 ± 0.2 vs 4.2 ± 0.3,P &lt; 0.05). DMSO decreased the level of DAO in plasma compared with the ZS group(65.1 ± 4.7 U/L vs 81.1 ± 5.0 U/L,P &lt; 0.05). DMSO significantly preserved ZO-1 protein expression and localization 24 h after zymosan administration. The TUNEL analysis indicated that the number of apoptotic intestinal cells in the ZS group was much higher than the ZD group(P &lt; 0.05).CONCLUSION: DMSO inhibited intestinal cytokines and protected against zymosan-induced gut barrier dysfunction.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v21.i38.10853</identifier><identifier>PMID: 26478676</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Amine Oxidase (Copper-Containing) - blood ; Animals ; Apoptosis - drug effects ; Basic Study ; Dimethyl ; Dimethyl Sulfoxide - pharmacology ; Enteritis - chemically induced ; Enteritis - drug therapy ; Enteritis - metabolism ; Enteritis - pathology ; Free Radical Scavengers - pharmacology ; Interleukin-10 - metabolism ; Intestinal Mucosa - blood supply ; Intestinal Mucosa - drug effects ; Intestinal Mucosa - metabolism ; Intestinal Mucosa - pathology ; Male ; Malondialdehyde - metabolism ; Multiple Organ Failure - chemically induced ; Rats ; Rats, Sprague-Dawley ; Regional Blood Flow - drug effects ; sulfoxide;Zymosan;Inflammation;Intestinal ; Superoxide Dismutase - metabolism ; Systemic Inflammatory Response Syndrome - chemically induced ; Tight Junctions - drug effects ; Tumor Necrosis Factor-alpha - metabolism ; Zonula Occludens-1 Protein - metabolism ; Zymosan</subject><ispartof>World journal of gastroenterology : WJG, 2015-10, Vol.21 (38), p.10853-10865</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-6aaa329c23cb795ae57e0cfbcecabccb02aa15ee0a9fabd65f93f5c193edfb313</citedby><cites>FETCH-LOGICAL-c443t-6aaa329c23cb795ae57e0cfbcecabccb02aa15ee0a9fabd65f93f5c193edfb313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600586/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600586/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27926,27927,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26478676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Yu-Meng</creatorcontrib><creatorcontrib>Wang, Hai-Bin</creatorcontrib><creatorcontrib>Zheng, Jin-Guang</creatorcontrib><creatorcontrib>Bai, Xiao-Dong</creatorcontrib><creatorcontrib>Zhao, Zeng-Kai</creatorcontrib><creatorcontrib>Li, Jing-Yuan</creatorcontrib><creatorcontrib>Hu, Sen</creatorcontrib><title>Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To investigate whether dimethyl sulfoxide(DMSO) inhibits gut inflammation and barrier dysfunction following zymosan-induced systemic inflammatoryresponse syndrome and multiple organ dysfunction syndrome.METHODS: Sprague-Dawley rats were randomly divided into four groups: sham with administration of normal saline(SS group); sham with administration of DMSO(SD group); zymosan with administration of normal saline(ZS group); and zymosan with administration of DMSO(ZD group). Each group contained three subgroups according to 4 h,8 h,and 24 h after surgery. At 4 h,8 h,and 24 h after intraperitoneal injection of zymosan(750 mg/kg),the levels of intestinal inflammatory cytokines [tumor necrosis factor-alpha(TNF-α) and interleukin(IL)-10] and oxides(myeloperoxidase,malonaldehyde,and superoxide dismutase) were examined. The levels of diamine oxidase(DAO) in plasma and intestinal mucosal blood flow(IMBF) were determined. Intestinal injury was also evaluated using an intestinal histological score and apoptosis of intestinal epithelial cells was determined by deoxynucleotidyl transferase d UTP nick end labeling(TUNEL) assay. The intestinal epithelial tight junction protein,ZO-1,was observed by immunofluorescence.RESULTS: DMSO decreased TNF-α and increased IL-10 levels in the intestine compared with the ZS group at the corresponding time points. The activity of intestinal myeloperoxidase in the ZS group was higher than that in the ZD group 24 h after zymosan administration(P &lt; 0.05). DMSO decreased the content of malondialdehyde(MDA) and increased the activity of superoxide dehydrogenase(SOD) 24 h after zymosan administration. The IMBF was lowest at 24 h and was 49.34% and 58.26% in the ZS group and ZD group,respectively(P &lt; 0.05). DMSO alleviated injury in intestinal villi,and the gut injury score was significantly lower than the ZS group(3.6 ± 0.2 vs 4.2 ± 0.3,P &lt; 0.05). DMSO decreased the level of DAO in plasma compared with the ZS group(65.1 ± 4.7 U/L vs 81.1 ± 5.0 U/L,P &lt; 0.05). DMSO significantly preserved ZO-1 protein expression and localization 24 h after zymosan administration. The TUNEL analysis indicated that the number of apoptotic intestinal cells in the ZS group was much higher than the ZD group(P &lt; 0.05).CONCLUSION: DMSO inhibited intestinal cytokines and protected against zymosan-induced gut barrier dysfunction.</description><subject>Amine Oxidase (Copper-Containing) - blood</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Basic Study</subject><subject>Dimethyl</subject><subject>Dimethyl Sulfoxide - pharmacology</subject><subject>Enteritis - chemically induced</subject><subject>Enteritis - drug therapy</subject><subject>Enteritis - metabolism</subject><subject>Enteritis - pathology</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Interleukin-10 - metabolism</subject><subject>Intestinal Mucosa - blood supply</subject><subject>Intestinal Mucosa - drug effects</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Intestinal Mucosa - pathology</subject><subject>Male</subject><subject>Malondialdehyde - metabolism</subject><subject>Multiple Organ Failure - chemically induced</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Regional Blood Flow - drug effects</subject><subject>sulfoxide;Zymosan;Inflammation;Intestinal</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Systemic Inflammatory Response Syndrome - chemically induced</subject><subject>Tight Junctions - drug effects</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Zonula Occludens-1 Protein - metabolism</subject><subject>Zymosan</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU9v1DAQxS0EokvhA3BBOXLJ4r-JfUFChQJSJS7tiYM1duxdV4nd2klh--nxtsuqncuM_N482_oh9J7gNeu5_PTnerO-o2QdmFwTLAV7gVaUEtVSyfFLtCIY961itD9Bb0q5xpgyJuhrdEI73suu71bo99cwuXm7G5uyjD79DYNrQtwGE-bS3O-mVCC2IQ6LdUMVZlfmEGGsox9hmmAOKTYQh8ZAzsHlZtgVv0S7P3-LXnkYi3t36Kfo6vzb5dmP9uLX959nXy5ayzmb2w4AGFWWMmt6JcCJ3mHrjXUWjLUGUwAinMOgPJihE14xLyxRzA3eMMJO0efH3JvFTG6wLs4ZRn2TwwR5pxME_VyJYas36U7zDmMhuxrw8RCQ0-1Sv6inUKwbR4guLUWTnnLaEcFltZJHq82plOz88RqC9R6KrlB0haIrFP0Ape58ePq-48Z_CtXADqHbFDe3IW6OHoXlvpTAXHIlmCCie5g4-weAQ545</recordid><startdate>20151014</startdate><enddate>20151014</enddate><creator>Li, Yu-Meng</creator><creator>Wang, Hai-Bin</creator><creator>Zheng, Jin-Guang</creator><creator>Bai, Xiao-Dong</creator><creator>Zhao, Zeng-Kai</creator><creator>Li, Jing-Yuan</creator><creator>Hu, Sen</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151014</creationdate><title>Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction</title><author>Li, Yu-Meng ; Wang, Hai-Bin ; Zheng, Jin-Guang ; Bai, Xiao-Dong ; Zhao, Zeng-Kai ; Li, Jing-Yuan ; Hu, Sen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-6aaa329c23cb795ae57e0cfbcecabccb02aa15ee0a9fabd65f93f5c193edfb313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Amine Oxidase (Copper-Containing) - blood</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Basic Study</topic><topic>Dimethyl</topic><topic>Dimethyl Sulfoxide - pharmacology</topic><topic>Enteritis - chemically induced</topic><topic>Enteritis - drug therapy</topic><topic>Enteritis - metabolism</topic><topic>Enteritis - pathology</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Interleukin-10 - metabolism</topic><topic>Intestinal Mucosa - blood supply</topic><topic>Intestinal Mucosa - drug effects</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Intestinal Mucosa - pathology</topic><topic>Male</topic><topic>Malondialdehyde - metabolism</topic><topic>Multiple Organ Failure - chemically induced</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Regional Blood Flow - drug effects</topic><topic>sulfoxide;Zymosan;Inflammation;Intestinal</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Systemic Inflammatory Response Syndrome - chemically induced</topic><topic>Tight Junctions - drug effects</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Zonula Occludens-1 Protein - metabolism</topic><topic>Zymosan</topic><toplevel>online_resources</toplevel><creatorcontrib>Li, Yu-Meng</creatorcontrib><creatorcontrib>Wang, Hai-Bin</creatorcontrib><creatorcontrib>Zheng, Jin-Guang</creatorcontrib><creatorcontrib>Bai, Xiao-Dong</creatorcontrib><creatorcontrib>Zhao, Zeng-Kai</creatorcontrib><creatorcontrib>Li, Jing-Yuan</creatorcontrib><creatorcontrib>Hu, Sen</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yu-Meng</au><au>Wang, Hai-Bin</au><au>Zheng, Jin-Guang</au><au>Bai, Xiao-Dong</au><au>Zhao, Zeng-Kai</au><au>Li, Jing-Yuan</au><au>Hu, Sen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2015-10-14</date><risdate>2015</risdate><volume>21</volume><issue>38</issue><spage>10853</spage><epage>10865</epage><pages>10853-10865</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To investigate whether dimethyl sulfoxide(DMSO) inhibits gut inflammation and barrier dysfunction following zymosan-induced systemic inflammatoryresponse syndrome and multiple organ dysfunction syndrome.METHODS: Sprague-Dawley rats were randomly divided into four groups: sham with administration of normal saline(SS group); sham with administration of DMSO(SD group); zymosan with administration of normal saline(ZS group); and zymosan with administration of DMSO(ZD group). Each group contained three subgroups according to 4 h,8 h,and 24 h after surgery. At 4 h,8 h,and 24 h after intraperitoneal injection of zymosan(750 mg/kg),the levels of intestinal inflammatory cytokines [tumor necrosis factor-alpha(TNF-α) and interleukin(IL)-10] and oxides(myeloperoxidase,malonaldehyde,and superoxide dismutase) were examined. The levels of diamine oxidase(DAO) in plasma and intestinal mucosal blood flow(IMBF) were determined. Intestinal injury was also evaluated using an intestinal histological score and apoptosis of intestinal epithelial cells was determined by deoxynucleotidyl transferase d UTP nick end labeling(TUNEL) assay. The intestinal epithelial tight junction protein,ZO-1,was observed by immunofluorescence.RESULTS: DMSO decreased TNF-α and increased IL-10 levels in the intestine compared with the ZS group at the corresponding time points. The activity of intestinal myeloperoxidase in the ZS group was higher than that in the ZD group 24 h after zymosan administration(P &lt; 0.05). DMSO decreased the content of malondialdehyde(MDA) and increased the activity of superoxide dehydrogenase(SOD) 24 h after zymosan administration. The IMBF was lowest at 24 h and was 49.34% and 58.26% in the ZS group and ZD group,respectively(P &lt; 0.05). DMSO alleviated injury in intestinal villi,and the gut injury score was significantly lower than the ZS group(3.6 ± 0.2 vs 4.2 ± 0.3,P &lt; 0.05). DMSO decreased the level of DAO in plasma compared with the ZS group(65.1 ± 4.7 U/L vs 81.1 ± 5.0 U/L,P &lt; 0.05). DMSO significantly preserved ZO-1 protein expression and localization 24 h after zymosan administration. The TUNEL analysis indicated that the number of apoptotic intestinal cells in the ZS group was much higher than the ZD group(P &lt; 0.05).CONCLUSION: DMSO inhibited intestinal cytokines and protected against zymosan-induced gut barrier dysfunction.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>26478676</pmid><doi>10.3748/wjg.v21.i38.10853</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2015-10, Vol.21 (38), p.10853-10865 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4600586 |
source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Amine Oxidase (Copper-Containing) - blood Animals Apoptosis - drug effects Basic Study Dimethyl Dimethyl Sulfoxide - pharmacology Enteritis - chemically induced Enteritis - drug therapy Enteritis - metabolism Enteritis - pathology Free Radical Scavengers - pharmacology Interleukin-10 - metabolism Intestinal Mucosa - blood supply Intestinal Mucosa - drug effects Intestinal Mucosa - metabolism Intestinal Mucosa - pathology Male Malondialdehyde - metabolism Multiple Organ Failure - chemically induced Rats Rats, Sprague-Dawley Regional Blood Flow - drug effects sulfoxide Zymosan Inflammation Intestinal Superoxide Dismutase - metabolism Systemic Inflammatory Response Syndrome - chemically induced Tight Junctions - drug effects Tumor Necrosis Factor-alpha - metabolism Zonula Occludens-1 Protein - metabolism Zymosan |
title | Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A40%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dimethyl%20sulfoxide%20inhibits%20zymosan-induced%20intestinal%20inflammation%20and%20barrier%20dysfunction&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Li,%20Yu-Meng&rft.date=2015-10-14&rft.volume=21&rft.issue=38&rft.spage=10853&rft.epage=10865&rft.pages=10853-10865&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v21.i38.10853&rft_dat=%3Cproquest_pubme%3E1724261548%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1724261548&rft_id=info:pmid/26478676&rft_cqvip_id=90888889504849535156484954&rfr_iscdi=true |